An increase in FR-α expression is a common trait observed in most gliomas (26) and many other cancer types (5–7) and recent studies have demonstrated that an overexpression of FR-α is very often conserved from primary tumors to secondary metastases e.g., in breast cancer (27). Here, FOLR1 is linked to central nervous system cancer.